BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30011933)

  • 1. Mechanisms of Tumor Growth Inhibition by Depletion of γ-Glutamylcyclotransferase (GGCT): A Novel Molecular Target for Anticancer Therapy.
    Kageyama S; Ii H; Taniguchi K; Kubota S; Yoshida T; Isono T; Chano T; Yoshiya T; Ito K; Yoshiki T; Kawauchi A; Nakata S
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma-Glutamylcyclotransferase: A Novel Target Molecule for Cancer Diagnosis and Treatment.
    Kageyama S; Hanada E; Ii H; Tomita K; Yoshiki T; Kawauchi A
    Biomed Res Int; 2015; 2015():345219. PubMed ID: 26339607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of γ-Glutamylcyclotransferase Enhances Docetaxel Growth Inhibition of Prostate Cancer Cells.
    Takagi H; Ii H; Kageyama S; Hanada E; Taniguchi K; Yoshiya T; Chano T; Kawauchi A; Nakata S
    Anticancer Res; 2019 Sep; 39(9):4811-4816. PubMed ID: 31519583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Prodrug of a γ-Glutamylcyclotransferase Inhibitor Suppresses Cancer Cell Proliferation in vitro and Inhibits Tumor Growth in a Xenograft Mouse Model of Prostate Cancer.
    Ii H; Yoshiya T; Nakata S; Taniguchi K; Hidaka K; Tsuda S; Mochizuki M; Nishiuchi Y; Tsuda Y; Ito K; Kageyama S; Yoshiki T
    ChemMedChem; 2018 Jan; 13(2):155-163. PubMed ID: 29316360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of gamma-glutamylcyclotransferase inhibits cancer cell growth by activating the AMPK-FOXO3a-p21 axis.
    Taniguchi K; Ii H; Kageyama S; Takagi H; Chano T; Kawauchi A; Nakata S
    Biochem Biophys Res Commun; 2019 Sep; 517(2):238-243. PubMed ID: 31345573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of GGCT inhibits cell proliferation and induces late apoptosis in human gastric cancer.
    Zhang W; Chen L; Xiang H; Hu C; Shi W; Dong P; Lv W
    BMC Biochem; 2016 Dec; 17(1):19. PubMed ID: 27905872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of U83836E as a γ-glutamylcyclotransferase inhibitor that suppresses MCF7 breast cancer xenograft growth.
    Ii H; Nohara Y; Yoshiya T; Masuda S; Tsuda S; Oishi S; Friedman J; Kawabe T; Nakata S
    Biochem Biophys Res Commun; 2021 Apr; 549():128-134. PubMed ID: 33676180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-GA, a Novel Inhibitor of γ-Glutamylcyclotransferase, Suppresses Human Bladder Cancer Cell Growth.
    Hanada E; Kageyama S; Murai R; Kubota S; Ii H; Nakata S; Kita H; Kawauchi A; Chano T
    Anticancer Res; 2019 Apr; 39(4):1893-1898. PubMed ID: 30952730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-glutamylcyclotransferase promotes the growth of human glioma cells by activating Notch-Akt signaling.
    Shen SH; Yu N; Liu XY; Tan GW; Wang ZX
    Biochem Biophys Res Commun; 2016 Mar; 471(4):616-20. PubMed ID: 26828272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated hyaluronic acid-modified liposomal delivery system with anti-γ-glutamylcyclotransferase siRNA for drug-resistant MCF-7 breast cancer therapy.
    Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Fu H; Zhang Z; He Q
    J Pharm Sci; 2015 Feb; 104(2):476-84. PubMed ID: 25256603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. γ-Glutamylcyclotransferase Knockdown Inhibits Growth of Lung Cancer Cells Through G0/G1 Phase Arrest.
    Lin Z; Xiong L; Zhou J; Wang J; Li Z; Hu H; Lin Q
    Cancer Biother Radiopharm; 2015 Jun; 30(5):211-6. PubMed ID: 25941902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and GGCT Inhibitory Activity of N-Glutaryl-L-alanine Analogues.
    Ii H; Yoshiki T; Hoshiya N; Uenishi J
    Chem Pharm Bull (Tokyo); 2016; 64(7):785-92. PubMed ID: 27373633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of Gapmer-type Antisense Oligonucleotides Targeting γ-Glutamylcyclotransferase Suppresses the Growth of A549 Lung Cancer Xenografts.
    Ii H; Kasahara Y; Yamaguma H; Kageyama S; Kawauchi A; Obika S; Nakata S
    Anticancer Res; 2022 Mar; 42(3):1221-1227. PubMed ID: 35220212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prohibitin-2 is a novel regulator of p21
    Taniguchi K; Matsumura K; Kageyama S; Ii H; Ashihara E; Chano T; Kawauchi A; Yoshiki T; Nakata S
    Biochem Biophys Res Commun; 2018 Jan; 496(1):218-224. PubMed ID: 29307834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fluorescence-based microtiter plate assay for γ-glutamylcyclotransferase.
    Board PG; Hutchinson I
    Anal Biochem; 2012 Jan; 420(2):177-81. PubMed ID: 22001377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of γ-glutamyl cyclotransferase as a therapeutic target for colorectal cancer based on the lentivirus-mediated system.
    Dong J; Zhou Y; Liao Z; Huang Q; Feng S; Li Y
    Anticancer Drugs; 2016 Nov; 27(10):1011-20. PubMed ID: 27500968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of γ-glutamylcyclotransferase inhibits breast cancer cell growth via cellular senescence induction mediated by CDK inhibitor upregulation.
    Matsumura K; Nakata S; Taniguchi K; Ii H; Ashihara E; Kageyama S; Kawauchi A; Yoshiki T
    BMC Cancer; 2016 Sep; 16(1):748. PubMed ID: 27658708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of gamma-glutamylcyclotransferase in cancer cells induces autophagy followed by cellular senescence.
    Taniguchi K; Matsumura K; Ii H; Kageyama S; Ashihara E; Chano T; Kawauchi A; Yoshiki T; Nakata S
    Am J Cancer Res; 2018; 8(4):650-661. PubMed ID: 29736310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. γ-Glutamyl cyclotransferase contributes to endometrial carcinoma malignant progression and upregulation of PD-L1 expression during activation of epithelial-mesenchymal transition.
    Xu S; Yang Y; Wang X; Liu X; Jin C; Ma M; Wu S; Li Y
    Int Immunopharmacol; 2020 Apr; 81():106039. PubMed ID: 31757677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway.
    Li Y; Wu T; Wang Y; Yang L; Hu C; Chen L; Wu S
    Gynecol Oncol; 2018 Apr; 149(1):163-172. PubMed ID: 29429592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.